c-Met protein OE was associated with poor prognosis in these real-world patients; for patients with c-Met protein–overexpressing NSCLC versus no OE, the unadjusted hazard ratio for death was 2.04 (95% CI: 1.02, 4.10) (Figure 5). The gene discussed is MET; the disease is non-small cell lung carcinoma.